Plain-English translation of NCT07555574 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Age-Related Macular Degeneration research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new type of camera called hyperspectral retinal imaging (HSI) that takes very detailed pictures of the back of your eye. Unlike regular eye photography, this camera captures information across more than 25 different light wavelengths, giving doctors much richer information about the structures and tissues in your eye. The study is comparing these new images with standard eye imaging tests to see if HSI can better detect and diagnose eye diseases like age-related macular degeneration, diabetic retinopathy, and glaucoma.
Current eye imaging cameras show important information, but they may miss early signs of disease or subtle changes that could help doctors catch problems sooner. Researchers hope that this advanced camera technology will provide a clearer picture of eye disease and lead to better, earlier diagnosis and treatment.
You likely qualify if…
You likely don't qualify if…
You will visit the Centre for Eye Research Australia for one study appointment. During your visit, you will have a standard eye exam and your pupils will be dilated with eye drops. Then you will undergo the new hyperspectral imaging (which is painless and non-invasive, similar to regular eye photography) and standard eye imaging tests like OCT and fundus photography. The entire process typically takes a few hours, and there is no follow-up treatment—this is purely a research imaging study to help develop better diagnostic tools.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Australia